Members of an advisory panel have proposed adding warning labels to some medication about adverse maternal and fetal risks in pregnancy.

Wall Street expects a year-over-year decline in earnings on higher revenues when Inspire Medical Systems (INSP) reports ...

An Instagram reel claims that a Mix of Flaxseed Oil and Homemade Paneer Cures Cancer. The claim is FALSE.ClaimIn an Instagram reel claims that Mix of Flaxseed Oil and Homemade Paneer Cures ...

List today: Medpace Holdings, Inc. MEDP: This clinical research-based drug and medical devices company has seen the Zacks ...

CNC has offered FY2025 adj EPS range at between $1.25 (-82.5% YoY) and $1.75 (-75.5% YoY), as medical costs rise drastically ...

Medical Properties Trust, Inc. MPW — also known as MPT — is scheduled to report second-quarter 2025 earnings results on July ...

There is broad consensus that the overall body of evidence shows lowering LDL (low-density lipoprotein) cholesterol provides ...

Community Healthcare is positioned in the middle among its peers for Consensus rating. It ranks at the bottom for Revenue Growth. In terms of Gross Profit, it is at the bottom compared to its peers.

Pregnancy presents a unique ethical dilemma. The unborn child cannot give consent, and damage sustained in the womb can ...

CRS is expected to see Q4 earnings growth despite lower sales, with aerospace demand and higher margins offsetting headwinds.

Key Points Revenue climbed to $5.06 billion in Q2 2025, up 23% from the prior year period and 3.4% above analyst expectations. Adjusted EPS reached $0.75 for Q2 2025, exceeding estimates for the ...